Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer

Annals of Surgery

Volumn 236, Issue 2, 2002, Pages 184-190

  Sato, Nobuhiro ^a   Koeda, Keisuke ^a   Ikeda, Kenichiro ^a   Kimura, Yusuke ^a   Aoki, Kiichi ^a   Iwaya, Takeshi ^a   Akiyama, Yuji ^a   Ishida, Kaoru ^a   Saito, Kazuyoshi ^a   Endo, Shigeatsu ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; MORBIDITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SURGICAL MORTALITY; SURGICAL STRESS;

AGED; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CYTOKINES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MORBIDITY; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; STRESS; SURVIVAL ANALYSIS;

EID: 0036320338     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200208000-00006     Document Type: Article

References (34)

1. Elevation of circulating interleukin-6 after surgery
2. Pulmonary hypertension and polymorphonuclear leukocyte elastase after esophageal cancer operation
3. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery
4. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
5. An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
6. Sir Isaac Newton, sepsis, SIRS, CARS
7. Biologic control of injury and inflammation: Much more than too little or too late
8. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
9. Detrimental effect of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock
10. Mineralcorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element
11. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors
12. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome
13. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass
14. Tubular nephrotoxicity after cardiac surgery utilizing cardiopulmonary bypass
15. Surgical wound infection rates by wound class, operative procedure, and patient risk index
16. National Nosocomial Infections Surveillance System (NNIS): Description of surveillance methods
17. Changes in the surgical management of esophageal cancer from 1970 to 1993
18. Results of nationwide study on the three-field lymph node dissection of esophageal cancer
19. Operable esophageal carcinoma: Current results from Hong Kong
20. Effect of preoperative methylprednisolone infusion on stress response in patients undergoing esophageal cancer surgery
21. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years
22. Risks and benefits of preoperative high-dose methylprednisolone in surgical patients
23. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus
24. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
25. Corticosteroids and bioavailability
26. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 Pm
27. Cellular immunity after intravenous administration of methylprednisolone
28. Interleukin-10 signaling blocks inhibitor of kappa-B kinase activity and nuclear factor kappa-B DNA binding
29. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3
30. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF-synthesis may explain IL-1-induced resistance to infection
31. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis: Identification of a single site in IL-1ra and two sites in IL-1 beta